ArticleFrontiers in oncology2024

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer.

Andrew Takchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.